CompletedPhase 2NCT01357681

Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)

Studying Huntington disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Charite University, Berlin, Germany
Principal Investigator
Josef Priller, MD
Department of Neuropsychiatry, Charité Universitätsmedizin Berlin, Germany
Intervention
(2)-epigallocatechin-3-gallate (EGCG)(drug)
Enrollment
54 enrolled
Eligibility
18 years · All sexes
Timeline
2011 – 2015

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01357681 on ClinicalTrials.gov

Other trials for Huntington disease

Additional recruiting or active studies for the same condition.

See all trials for Huntington disease →

← Back to all trials